Home  »  Technologies   »  Should Aura Biosciences Inc. (NASDAQ: AURA) Rally ...

Should Aura Biosciences Inc. (NASDAQ: AURA) Rally After -139.9% Drop From High?

Aura Biosciences Inc. (NASDAQ:AURA)’s traded shares stood at 1.04 million during the last session. At the close of trading, the stock’s price was $10.35, to imply an increase of 1.37% or $0.14 in intraday trading. The AURA share’s 52-week high remains $24.83, putting it -139.9% down since that peak but still an impressive 8.89% since price per share fell to its 52-week low of $9.43. The company has a valuation of $382.85M, with an average of 0.11 million shares in intraday trading volume over the past 10 days and average of 90.92K shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Aura Biosciences Inc. (AURA), translating to a mean rating of 1.60. Of 5 analyst(s) looking at the stock, 0 analyst(s) give AURA a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.54.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


Aura Biosciences Inc. (NASDAQ:AURA) trade information

After registering a 1.37% upside in the last session, Aura Biosciences Inc. (AURA) has traded red over the past five days. The stock hit a weekly high of 10.83 this Friday, 03/17/23, jumping 1.37% in its intraday price action. The 5-day price performance for the stock is 3.50%, and -7.17% over 30 days. With these gigs, the year-to-date price performance is -1.43%. Short interest in Aura Biosciences Inc. (NASDAQ:AURA) saw shorts transact 0.62 million shares and set a 6.08 days time to cover.

Analysts on Wall Street suggest a consensus price target of $30.50, implying an increase of 66.07% to the stock’s current value. The extremes give us $25.00 and $38.00 for target low and target high price respectively. As such, AURA has been trading -267.15% off suggested target high and -141.55% from its likely low.

Aura Biosciences Inc. (AURA) estimates and forecasts

Looking at statistics comparing Aura Biosciences Inc. share performance against respective industry, we note that the company has underperformed competitors. Aura Biosciences Inc. (AURA) shares are -27.97% down over the last 6 months, with its year-to-date growth rate lower than industry average at -29.08% against 9.60%. Revenue is forecast to grow 78.50% this quarter before falling -29.50% for the next one.

AURA Dividends

Aura Biosciences Inc. has its next earnings report out on August 11. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Aura Biosciences Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Aura Biosciences Inc. (NASDAQ:AURA)’s Major holders

Aura Biosciences Inc. insiders hold 8.44% of total outstanding shares, with institutional holders owning 62.30% of the shares at 68.05% float percentage. In total, 62.30% institutions holds shares in the company, led by Matrix Capital Management. As of Sep 29, 2022, the company held over 4.11 million shares (or 14.02% of shares), all amounting to roughly $74.53 million.

The next major institution holding the largest number of shares is Medicxi Ventures Management (Jersey) Ltd with 3.04 million shares, or about 10.36% of shares outstanding. As of the market price on Dec 30, 2022, these shares were worth $31.92 million.

We also have Fidelity Select Portfolios – Biotechnology and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Aura Biosciences Inc. (AURA) shares. Going by data provided on Nov 29, 2022, Fidelity Select Portfolios – Biotechnology holds roughly 0.52 million shares. This is just over 1.77% of the total shares, with a market valuation of $7.43 million. Data from the same date shows that the other fund manager holds a little less at 0.41 million, or 1.41% of the shares, all valued at about 4.33 million.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts